.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing pituitary adenoma requires precise monitoring of postoperative morning cortisol levels. Recent research highlights that these levels serve as robust predictors for secondary adrenal insufficiency (SAI). Specifically, clinicians can use these markers to determine which patients require long-term glucocorticoid replacement. Furthermore, this approach reduces unnecessary testing while ensuring patient safety during the recovery phase.
The study suggests that POD2 cortisol measurements offer superior predictive accuracy compared to POD1. Although POD1 is a common benchmark, the second-day measurement provides a more stable reflection of the hypothalamic-pituitary-adrenal axis. Consequently, identifying patients at risk of SAI becomes more reliable. Researchers found that a POD2 morning cortisol cutoff of 12.3 µg/dL achieved a 100% negative predictive value. Therefore, patients exceeding this threshold may safely avoid long-term steroid therapy.
Besides adrenal function, patients often experience other endocrine deficiencies after pituitary resection. These include hypogonadism, hypothyroidism, and growth hormone deficiency. Additionally, arginine vasopressin deficiency remains a concern. Because persistent hypopituitarism affects nearly one-fourth of patients, consistent follow-up is mandatory. However, POD2 cortisol remains the strongest predictor for the most critical deficiency: secondary adrenal insufficiency.
A level of 12.3 µg/dL acts as the optimal threshold for predicting long-term adrenal sufficiency with high confidence.
POD2 measurements demonstrate higher discriminative performance with an AUC of 0.990, compared to 0.719 for POD1.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.
References
Liu KG et al. Postoperative days 1 and 2 morning cortisol levels as predictors of long-term secondary adrenal insufficiency following pituitary adenoma surgery. J Neurosurg. 2026 Feb 06. doi: 10.3171/2025.9.JNS251261. PMID: 41650448.
Elshimy G et al. Early Morning Cortisol Level as a Predictive Factor for Long-Term Glucocorticoid Replacement After Pituitary Surgery: A Systematic Review and Meta-Analysis. Pituitary. 2023.
Endocrine Society. Clinical Practice Guideline: Management of Pituitary Surgery Outcomes and Adrenal Insufficiency. 2024.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research identifies POD2 morning cortisol (cutoff 12.3 µg/dL) as a superior predictor of long-term secondary adrenal insufficiency post-pituitary surger...
7 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
